Showing results (871-880 of 1,873) with videos related to

Sort By:
Pageof 188
Pulmonary Pharmacology & Therapeutics|March 11, 2023
Anlotinib prove to be a potential therapy for the treatment of pulmonary fibrosis complicated with lung adenocarcinomaShanshan Chen, Dandi Gao, Ronghao Sun, et al.
Pulmonary Pharmacology & Therapeutics|July 30, 2016
Evaluation of adiponectin profile in Italian patients affected by obstructive sleep apnea syndromeDonato Lacedonia, Ersilia Nigro, Maria Gabriella Matera, et al.
Pulmonary Pharmacology & Therapeutics|July 14, 2015
The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cellsMutsuo Yamaya, Yoshitaka Shimotai, Yukimasa Hatachi, et al.
Pulmonary Pharmacology & Therapeutics|August 17, 2021
Long non-coding RNA LINC01224 promotes progression and cisplatin resistance in non-small lung cancer by sponging miR-2467Shumei Xiao, Longhua Sun, Bin Ruan, et al.
Pulmonary Pharmacology & Therapeutics|January 10, 2026
Setting expectations with oral selexipag: an expert consensus-based approach on best practices to initiate, dose, titrate, and manage side effects (SEs) in patients with pulmonary arterial hypertension (PAH)Sheryl E Wu, Jeremy A Mazurek, Jennalyn D Mayeux, et al.
Pulmonary Pharmacology & Therapeutics|June 4, 2025
Effects of EP395, a novel macrolide, on acute neutrophilic airway inflammationJennifer Ann Kricker, Virginia Norris, Clive Page, et al.
Pulmonary Pharmacology & Therapeutics|July 31, 2025
Icaritin protects against airway inflammation by inhibiting the TLR4/NF-κB pathway in vivo and in vitroBo Xiao, Guiming Zhou, Lixia Hou, et al.
Pulmonary Pharmacology & Therapeutics|February 19, 2026
Posaconazole attenuates arsenic trioxide toxicity and enhances safety and efficacy while reducing invasion and metastasis in non-small-cell lung cancerShima Karami, Azra Rabbani-Chadegani, Jamshid Davoodi
Pulmonary Pharmacology & Therapeutics|March 11, 2024
The incidence and prognosis of other iatrogenic immunodeficiency-associated lymphoproliferative disorders of the lung related to methotrexate: A retrospective studyAtsushi Torii, Masahide Oki, Hiroatsu Iida, et al.
Pulmonary Pharmacology & Therapeutics|November 7, 2023
IRE1α/XBP-1 promotes β-catenin signaling activation of airway epithelium in lipopolysaccharide-induced acute lung injuryHailing Zhang, Jiehong Li, Xilong Wang, et al.
Pageof 188